Clinical trial
Ertugliflozin in Chronic Heart Failure
NCT04438213
Study timeline
Study start (actual)2021-03-10Date precision: day
Registry last updated2025-10-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Interventions
Sponsors & collaborators
Yale Universitylead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04438213 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.